Point-of-care testing for HIV viral load and drug resistance
V-OLA point-of-care HIV viral load monitoring and drug resistance testing
This study is working on a new, easy-to-use test that helps people with HIV check their viral load and see if their treatment is still working, so they can get the right care more often and avoid complications.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11012388 on NIH RePORTER |
What this research studies
This research focuses on developing a point-of-care test that allows for frequent monitoring of HIV viral load and drug resistance in patients living with HIV. Currently, many patients undergo viral load testing infrequently, which can lead to delays in identifying treatment failures and the spread of drug-resistant HIV. By implementing a more accessible testing method, the research aims to differentiate between issues of medication adherence and actual drug resistance, ultimately improving patient management and outcomes. The approach involves creating algorithms and testing methods that align with WHO recommendations for effective HIV treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who require regular monitoring of their viral load and may be experiencing treatment failures.
Not a fit: Patients who are not living with HIV or those who are already receiving optimal and effective treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more timely and accurate treatment adjustments for patients living with HIV, reducing the risk of drug resistance and improving overall health outcomes.
How similar studies have performed: Other research has shown success with similar point-of-care testing approaches, indicating potential for impactful advancements in HIV management.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Lutz, Barry Ryan — University of Washington
- Study coordinator: Lutz, Barry Ryan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.